Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Accenture
Baxter
Fish and Richardson
Express Scripts
Julphar

Generated: September 18, 2019

DrugPatentWatch Database Preview

Patent: 7,667,114

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,667,114
Title:Starch branching enzyme
Abstract: This invention relates to a new starch branching enzyme, and to the gene encoding the enzyme. In particular, the invention provides a new starch branching enzyme type II from wheat, the nucleic acid encoding the enzyme, and constructs comprising the nucleic acid. The invention also relates to a novel method for identification of branching enzyme type II proteins, which is useful for screening wheat germplasm for null or altered alleles of wheat branching enzyme IIb. The novel gene, protein and methods of the invention are useful in production of plants which produce grain with novel properties for food and industrial applications, for example wheat grain containing high amylose or low amylopectin starch.
Inventor(s): Morell; Matthew (Australian Capital Territory, AU), Rahman; Sadequr (Melba, Australian Capital Territory, AU), Regina; Ahmed (Australian Capital Territory, AU)
Assignee: Commonwealth Scientific and Industrial Research Organisation (Campbell, AU) Biogemma SAS (Paris, FR)
Application Number:10/204,347
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,667,114
Patent Claims:see list of patent claims

Details for Patent 7,667,114

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Commonwealth Scientific and Industrial Research Organisation (Campbell, AU) Biogemma SAS (Paris, FR) 2020-02-21 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Commonwealth Scientific and Industrial Research Organisation (Campbell, AU) Biogemma SAS (Paris, FR) 2020-02-21 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Commonwealth Scientific and Industrial Research Organisation (Campbell, AU) Biogemma SAS (Paris, FR) 2020-02-21 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Medtronic
Accenture
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.